Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/36028
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRoikjer, Johan-
dc.contributor.authorWerkman, Nikki C. C.-
dc.contributor.authorEjskjaer, Niels-
dc.contributor.authorVAN DEN BERGH, Joop-
dc.contributor.authorVestergaard, Peter-
dc.contributor.authorSchaper, Nicolaas C.-
dc.contributor.authorJensen, Morten Hasselstrom-
dc.contributor.authorKlungel, Olaf-
dc.contributor.authorde Vries, Frank-
dc.contributor.authorNielen, Johannes T. H.-
dc.contributor.authorDriessen, Johanna H. M.-
dc.date.accessioned2021-12-03T10:14:26Z-
dc.date.available2021-12-03T10:14:26Z-
dc.date.issued2022-
dc.date.submitted2021-11-05T13:55:58Z-
dc.identifier.citationDIABETIC MEDICINE, 39 (4) (Art N° e14725)-
dc.identifier.issn0742-3071-
dc.identifier.urihttp://hdl.handle.net/1942/36028-
dc.description.abstractAims A diabetic foot ulcer (DFU) is a severe condition associated with morbidity and mortality. Population-based studies are rare and limited by access to reliable data. Without this data, efforts in primary prevention cannot be evaluated. Therefore, we examined the incidence and changes over time for the first DFU in people with diabetes. We also examined hospitalization and all-cause mortality and their changes over time. Methods From the UK primary care CPRD GOLD database (2007-2017), we identified 129,624 people with diabetes by a prescription for insulin or a non-insulin anti-diabetic drug. DFUs were identified using Read codes and expressed as incidence rates (IRs). Changes over time were described using Poisson and logistic regression and expressed as incidence rate ratios (IRRs) and odds ratios (ORs) respectively. Results The mean IR of first registered DFUs was 2.5 [95% CI: 2.1-2.9] per 1000 person-years for people with type 2 diabetes and 1.6 [1.3-1.9] per 1000 person-years for people with type 1. The IRs declined for people with type 2 diabetes (IRR per year: 0.97 [0.96-0.99]), while no changes were observed for people with type 1 diabetes (IRR per year: 0.96 [0.89-1.04]). Average hospitalization and 1-year mortality risk for people with type 2 diabetes were 8.2% [SD: 4.7] and 11.7% [SD: 2.2] respectively. Both declined over time (OR: 0.89 [0.84, 0.94] and 0.94 [0.89, 0.99]). Conclusion The decline in all IRs, hospitalizations and mortality in people with type 2 diabetes suggests that prevention and care of the first DFU has improved for this group in primary care in the UK.-
dc.description.sponsorshipJ.R. wrote the manuscript, researched data, and contributed to the idea and study design. F.V., N.E., J.B., P.V., N.S., M.H. and O.K. contributed to the idea and study design, reviewed the manuscript, and conducted critical editing of written text. N.W. and J.N. reviewed the manuscript and conducted critical editing of written text. J.D. analysed data, contributed to the idea, study design, reviewed the manuscript and conducted critical editing of written text. Each author is accountable for his own contribution, disclosure of potential interests and approved the final version of the manuscript. F.V. is responsible for all aspects of the manuscript-
dc.language.isoen-
dc.publisherWILEY-
dc.rights2021 Diabetes UK-
dc.subject.otherdiabetes mellitus-
dc.subject.otherdiabetic foot disease-
dc.subject.otherdiabetic foot ulcer-
dc.subject.otherhospitalization-
dc.subject.othermortality-
dc.titleIncidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcer-
dc.typeJournal Contribution-
dc.identifier.issue4-
dc.identifier.volume39-
local.format.pages10-
local.bibliographicCitation.jcatA1-
dc.description.notesde Vries, F (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.-
dc.description.notesf.devries@uu.nl-
local.publisher.place111 RIVER ST, HOBOKEN 07030-5774, NJ USA-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.bibliographicCitation.artnre14725-
dc.identifier.doi10.1111/dme.14725-
dc.identifier.pmid34657300-
dc.identifier.isi000709871000001-
dc.contributor.orcidde Vries, Frank/0000-0003-3837-8319; schaper,-
dc.contributor.orcidnicolaas/0000-0002-2128-8029; Roikjer, Johan/0000-0002-4578-1328;-
dc.contributor.orcidDriessen, Johanna/0000-0002-4503-6408-
dc.identifier.eissn1464-5491-
local.provider.typewosris-
local.uhasselt.uhpubyes-
local.description.affiliation[Roikjer, Johan; Ejskjaer, Niels; Vestergaard, Peter; Jensen, Morten Hasselstrom] Steno Diabet Ctr North Denmark, Aalborg Univ Hosp, Aalborg, Denmark.-
local.description.affiliation[Roikjer, Johan; Jensen, Morten Hasselstrom] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark.-
local.description.affiliation[Werkman, Nikki C. C.; Schaper, Nicolaas C.; de Vries, Frank; Driessen, Johanna H. M.] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.-
local.description.affiliation[Werkman, Nikki C. C.; de Vries, Frank; Nielen, Johannes T. H.; Driessen, Johanna H. M.] Maastricht Univ, Dept Clin Pharm & Toxicol, Med Ctr, Maastricht, Netherlands.-
local.description.affiliation[Werkman, Nikki C. C.; Klungel, Olaf; de Vries, Frank; Driessen, Johanna H. M.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.-
local.description.affiliation[Ejskjaer, Niels; Vestergaard, Peter] Aalborg Univ Hosp, Clin Med & Endocrinol, Aalborg, Denmark.-
local.description.affiliation[van den Bergh, Joop P. W.] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands.-
local.description.affiliation[van den Bergh, Joop P. W.] VieCuri Med Ctr, Dept Internal Med, Venray, Netherlands.-
local.description.affiliation[van den Bergh, Joop P. W.] Hasselt Univ, Biomed Res Ctr, Hasselt, Belgium.-
local.description.affiliation[Schaper, Nicolaas C.] Maastricht Univ, Dept Internal Med, Div Endocrinol, Med Ctr, Maastricht, Netherlands.-
local.description.affiliation[Driessen, Johanna H. M.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Med Ctr, Maastricht, Netherlands.-
local.uhasselt.internationalyes-
item.validationecoom 2022-
item.contributorRoikjer, Johan-
item.contributorWerkman, Nikki C. C.-
item.contributorEjskjaer, Niels-
item.contributorVAN DEN BERGH, Joop-
item.contributorVestergaard, Peter-
item.contributorSchaper, Nicolaas C.-
item.contributorJensen, Morten Hasselstrom-
item.contributorKlungel, Olaf-
item.contributorde Vries, Frank-
item.contributorNielen, Johannes T. H.-
item.contributorDriessen, Johanna H. M.-
item.accessRightsRestricted Access-
item.fullcitationRoikjer, Johan; Werkman, Nikki C. C.; Ejskjaer, Niels; VAN DEN BERGH, Joop; Vestergaard, Peter; Schaper, Nicolaas C.; Jensen, Morten Hasselstrom; Klungel, Olaf; de Vries, Frank; Nielen, Johannes T. H. & Driessen, Johanna H. M. (2022) Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcer. In: DIABETIC MEDICINE, 39 (4) (Art N° e14725).-
item.fulltextWith Fulltext-
crisitem.journal.issn0742-3071-
crisitem.journal.eissn1464-5491-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
dme.14725.pdf
  Restricted Access
Published version278.1 kBAdobe PDFView/Open    Request a copy
Show simple item record

WEB OF SCIENCETM
Citations

6
checked on Apr 30, 2024

Page view(s)

34
checked on Sep 7, 2022

Download(s)

4
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.